Skip to Content

ASH 2023: FDA Approves Gene Therapies for Sickle Cell Disease

The US Food and Drug Administration’s approval of two gene therapies for sickle cell disease marks a significant advancement, offering potential cures to thousands affected by this genetic condition.

Get access

If you are a doctor, nurse, or other health professionals, you can access the entire article by creating a profile on BestPractice Nordic.

Back to top